irsogladine has been researched along with Gastritis in 2 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse effects were also compared." | 6.90 | The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis. ( Choi, SC; Hong, SJ; Jo, YJ; Kim, GH; Kim, HJ; Kim, JH; Kim, JI; Kim, JW; Kim, N; Kim, SG; Kwon, JG; Park, KS; Shim, KN; Shin, JE, 2019) |
| "Irsogladine, a mucosal protective drug, was developed in Japan for the treatment of peptic ulcer disease and acute gastritis." | 4.89 | Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract. ( Akagi, M; Amagase, K; Murakami, T; Takeuchi, K, 2013) |
| " Adverse effects were also compared." | 2.90 | The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis. ( Choi, SC; Hong, SJ; Jo, YJ; Kim, GH; Kim, HJ; Kim, JH; Kim, JI; Kim, JW; Kim, N; Kim, SG; Kwon, JG; Park, KS; Shim, KN; Shin, JE, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shim, KN | 1 |
| Kim, JI | 1 |
| Kim, N | 1 |
| Kim, SG | 1 |
| Jo, YJ | 1 |
| Hong, SJ | 1 |
| Shin, JE | 1 |
| Kim, GH | 1 |
| Park, KS | 1 |
| Choi, SC | 1 |
| Kwon, JG | 1 |
| Kim, JH | 1 |
| Kim, HJ | 1 |
| Kim, JW | 1 |
| Akagi, M | 1 |
| Amagase, K | 1 |
| Murakami, T | 1 |
| Takeuchi, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy in Patients With NSAIDs and Low Dose Steroid: A Single-center, Randomized, Open Labeled, Pilot Study[NCT04885751] | Phase 4 | 50 participants (Anticipated) | Interventional | 2021-06-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for irsogladine and Gastritis
| Article | Year |
|---|---|
Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract.
Topics: Animals; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Gastrointestinal Diseases; Helicobacter Infec | 2013 |
1 trial available for irsogladine and Gastritis
| Article | Year |
|---|---|
The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Me | 2019 |